The Food and Drug Administration (FDA) draft Guidance (Guidance) addressing the content and format of Dear Health Care Provider (DHCP) letters—which are sometimes called “Dear Doctor” letters—is the first substantive guidance from FDA on this issue.
Register now for your free, tailored, daily legal newsfeed service.
Questions? Please contact [email protected]
RegisterFDA draft guidance on Dear Health Care Provider letters carries potentially significant products liability implications
To view this article you need a PDF viewer such as Adobe Reader.
USA
November 19 2010
Popular articles from this firm
If you would like to learn how Lexology can drive your content marketing strategy forward, please email [email protected].
Related research hubs
Ian Anderson
In-house Counsel
Legal Delivery, Support & Partners
What our clients say
"Lexology is a valuable, trustworthy and informative source for domestic and International legal developments within a business related framework. The newsfeeds deliver high quality summaries from leading experts in a user-friendly format. Keep up the good work, it's most appreciated!."